Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Furin

Showing results (61-70 of 87) with videos related to

Pageof 9
Sort By:
Antimicrobial Agents and Chemotherapy|July 26, 2017
Population Pharmacokinetics of AZD-5847 in Adults with Pulmonary TuberculosisAbdullah Alsultan, Jennifer J Furin, Jeannine Du Bois, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|October 18, 2017
The devil we know: is the use of injectable agents for the treatment of MDR-TB justified?A Reuter, P Tisile, D von Delft, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|September 27, 2022
TB screening, prevention and treatment cascade in a Malawi prisonP Mangochi, C Bossard, C Catacutan, et al.
Antimicrobial Agents and Chemotherapy|August 24, 2016
Early Bactericidal Activity of AZD5847 in Patients with Pulmonary TuberculosisJennifer J Furin, Jeannine Du Bois, Elana van Brakel, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 13, 2026
When are uncontrolled trials in TB scientifically and ethically justified: Borrowing wisdom from early AIDS clinical trialsLindsay McKenna, Mike Frick, Valentina A Alarcón-Guizado, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|May 5, 2023
Best practices for the care of pregnant people living with TBC Maugans, M Loveday, S Hlangu, et al.
Journal of the Pediatric Infectious Diseases Society|May 30, 2013
Consensus Statement on Research Definitions for Drug-Resistant Tuberculosis in ChildrenJames A Seddon, Carlos M Perez-Velez, H Simon Schaaf, et al.
Annals of the New York Academy of Sciences|October 24, 2007
Treating multidrug-resistant tuberculosis in Tomsk, Russia: developing programs that address the linkage between poverty and diseaseS Keshavjee, I Y Gelmanova, A D Pasechnikov, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|October 31, 2020
Bedaquiline and delamanid result in low rates of unfavourable outcomes among TB patients in EswatiniD Vambe, A W Kay, J Furin, et al.
Plos One|September 20, 2014
Time to culture conversion and regimen composition in multidrug-resistant tuberculosis treatmentDylan B Tierney, Molly F Franke, Mercedes C Becerra, et al.
Pageof 9

Showing results (61-70 of 87) with videos related to

Sort By:
Pageof 9
Antimicrobial Agents and Chemotherapy|July 26, 2017
Population Pharmacokinetics of AZD-5847 in Adults with Pulmonary TuberculosisAbdullah Alsultan, Jennifer J Furin, Jeannine Du Bois, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|October 18, 2017
The devil we know: is the use of injectable agents for the treatment of MDR-TB justified?A Reuter, P Tisile, D von Delft, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|September 27, 2022
TB screening, prevention and treatment cascade in a Malawi prisonP Mangochi, C Bossard, C Catacutan, et al.
Antimicrobial Agents and Chemotherapy|August 24, 2016
Early Bactericidal Activity of AZD5847 in Patients with Pulmonary TuberculosisJennifer J Furin, Jeannine Du Bois, Elana van Brakel, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 13, 2026
When are uncontrolled trials in TB scientifically and ethically justified: Borrowing wisdom from early AIDS clinical trialsLindsay McKenna, Mike Frick, Valentina A Alarcón-Guizado, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|May 5, 2023
Best practices for the care of pregnant people living with TBC Maugans, M Loveday, S Hlangu, et al.
Journal of the Pediatric Infectious Diseases Society|May 30, 2013
Consensus Statement on Research Definitions for Drug-Resistant Tuberculosis in ChildrenJames A Seddon, Carlos M Perez-Velez, H Simon Schaaf, et al.
Annals of the New York Academy of Sciences|October 24, 2007
Treating multidrug-resistant tuberculosis in Tomsk, Russia: developing programs that address the linkage between poverty and diseaseS Keshavjee, I Y Gelmanova, A D Pasechnikov, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|October 31, 2020
Bedaquiline and delamanid result in low rates of unfavourable outcomes among TB patients in EswatiniD Vambe, A W Kay, J Furin, et al.
Plos One|September 20, 2014
Time to culture conversion and regimen composition in multidrug-resistant tuberculosis treatmentDylan B Tierney, Molly F Franke, Mercedes C Becerra, et al.
Pageof 9